In order to increase drug exports, Korean pharmaceutical companies are making investments to meet cGMP standards. The Korea Pharmaceutical Manufacturers Association estimates that the country’s 65 drug firms have invested KRW 1.9 trillion ($1.4 billion) over the past two years to upgrade their facilities. The country’s largest drug firm, Dong-A Pharmaceutical, intends to spend KRW […]
Early-stage contract research organizations (CROs) could face a tougher time in coming years, according to Jim Miller of PharmSource. After rapid growth in 2007 and early 2008, pharmaceutical outsourcing slowed in late 2008 due to restructuring at large drug companies and efforts to preserve cash by medium- and smaller-size pharmaceutical firms. The number of drug […]
Canadian science and technology (S&T) spending for biotechnology increased 4.6% in 2008 to $921 million to account for 9% of federal S&T expenditures. Twenty-nine percent of federal S&T spending for biotech went to in-house activities and 71% went to extramural performers. The higher education sector received 80% of extramural funding. Among S&T activities, R&D received […]
The US markets experienced another volatile month in March, but managed to ignite a sharp recovery after reaching new lows on March 9. The Dow Jones Industrial Average, S&P 500 and NASDAQ finished the month up 7.7%, 8.5% and 10.9%, respectively. Investor sentiment turned cautiously optimistic following a report that Citigroup recorded a significant operating […]
Company Announcements AMS and Westco Scientific Instruments acquired Unity Scientific, an NIR solutions provider, in fall 2008. Doug Evans remains president of Unity Scientific. Guided Wave acquired Aspectris, a supplier of encoded photometric IR and NIR systems to OEM customers and for selected target applications, in fall 2008. A2 Technologies licensed Boeing’s patents for the […]
Fourth-quarter 2008 IBO Life Science Index sales rose 1.7% to $2,416 million, while operating profits improved 1.3% to $435 million, and operating margins declined 10 basis points to 18.0% of revenues. For the year, Life Science Index sales grew 9.2% to $9,422 million. Operating profit climbed 15.6% to $1,556 million, and operating margins improved 90 […]
Darmstadt, Germany 3/3/09; Boca Raton, FL 3/3/09—AppliChem GmbH and Akron Biotechnology have merged, with Akron Biotech taking over AppliChem’s operations in the Americas on March 2 and adopting the AppliChem name. AppliChem offers biochemicals and reagents. Akron Biotechnology manufactures stem cell culture products. Dr. Claudia Zylvberberg will remain president and CEO of AppliChem.
Increases in National Health Service spending and other government funds for translational research has lead UK institutes to focus on moving medical research into the clinic more quickly. England is facing competition for medical research and clinical trials from the Asia-Pacific region. According to the Centers for Medicines Research, the number of patients enrolled in […]
Expectations for Pittcon were low this year. A worldwide recession and an ailing instrument market tempered any belief that the show’s attendance would rise dramatically. However, the fact that the conference took place in Chicago provided some hope that attendance figures would improve from last year, when the show was held in New Orleans, Louisiana […]
Company Announcements Sigma-Aldrich agreed to exclusively distribute research quantities of SouthWest NanoTechnologies’ SWeNT CG 100, SG 65 and SG 76 single-wall carbon nanotubes through its Aldrich division. In January, Sigma-Aldrich acquired the antibody-based Seppro affinity depletion technology and a library of 7,000 avian-derived antibodies from Genway Biotech. In December 2008, bioMerieux acquired PML Microbiologicals, a […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
